BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22652709)

  • 1. Alternative dialysis strategies with icodextrin.
    Panzer SE; Teitelbaum I
    Contrib Nephrol; 2012; 178():11-15. PubMed ID: 22652709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
    Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
    Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities.
    Fourtounas C; Hardalias A; Dousdampanis P; Papachristopoulos B; Savidaki E; Vlachojannis JG
    Adv Perit Dial; 2008; 24():27-31. PubMed ID: 18985997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falsely Elevated Glucose Concentrations in Peritoneal Dialysis Patients Using Icodextrin.
    Dogan K; Kayalp D; Ceylan G; Azak A; Senes M; Duranay M; Yucel D
    J Clin Lab Anal; 2016 Sep; 30(5):506-9. PubMed ID: 26511081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are current peritoneal dialysis solutions adequate for pediatric use?
    Verrina EE; Cannavò R; Schaefer B; Schmitt CP
    Contrib Nephrol; 2012; 178():16-22. PubMed ID: 22652710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2005; 21():21-4. PubMed ID: 16686279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.
    Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
    Perit Dial Int; 2009; 29(1):116-8. PubMed ID: 19164263
    [No Abstract]   [Full Text] [Related]  

  • 9. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
    Jenkins SB; Wilkie ME
    Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.
    Davies SJ; Brown EA; Frandsen NE; Rodrigues AS; Rodriguez-Carmona A; Vychytil A; Macnamara E; Ekstrand A; Tranaeus A; Filho JC;
    Kidney Int; 2005 Apr; 67(4):1609-15. PubMed ID: 15780118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the variability in ultrafiltration obtained with icodextrin.
    Lambie M; Stompor T; Davies S
    Perit Dial Int; 2009; 29(4):407-11. PubMed ID: 19602605
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of icodextrin on the peritoneal membrane. An inaccurate comment.
    Gotloib L
    Nephrol Dial Transplant; 2010 Sep; 25(9):3125-6; author reply 3126. PubMed ID: 20576721
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal reaction to icodextrin in a female patient on CAPD.
    Heering P; Brause M; Plum J; Grabensee B
    Perit Dial Int; 2001; 21(3):321-2. PubMed ID: 11475354
    [No Abstract]   [Full Text] [Related]  

  • 18. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
    Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
    J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients.
    Liakopoulos V; Zarogiannis S; Eleftheriadis T; Dovas S; Stefanidis I
    Perit Dial Int; 2007; 27(1):97-8. PubMed ID: 17179521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.